Samsung getting into biopharmaceuticals - Wants to become a leading pharmaceutical company 

05/15/2014 - 00:00

  <a href="">By Kanoko Matsuyama and Jungah Lee  -<br><br>South Korea’s biggest company is investing at least $2 billion in biopharmaceuticals, including the growing segment of biosimilars, which are cheaper versions of brand-name biotechnology drugs that have lost patent protection.<br><br>READ MORE ON BLOOMBERG</a>